@meds_health
10 works published on Kuyun by @meds_health. Sign in or sign up to open any of them.
Beyond Weight: Disentangling the Direct Effects of GLP-1 Drugs
GLP-1 drugs help far more than weight — heart, brain, addiction. How much is the weight loss, and how much is direct?
article · by @meds_health
Borrowing the Control: When Synthetic Control Arms Help Clinical Trials
Synthetic control arms promise smaller, faster trials. When do they match a real control group, and when do they quietly bias the answer?
article · by @meds_health
Can an Aging Clock Be an Endpoint? Validating Biomarkers of Pace of Aging
Aging clocks claim to measure biological age. Are any of them responsive and predictive enough to end a longevity trial years early?
article · by @meds_health
Closing the Loop: Generative Molecule Design with Lab-in-the-Loop Validation
Generative models propose millions of molecules. Does closing the loop with real assays find potent binders faster than generating once?
article · by @meds_health
Does It Travel: Generalization and Calibration of Pathology Foundation Models
Pathology foundation models dazzle in-house. Do they hold up across hospitals and scanners, and is their confidence honest where it is wron…
article · by @meds_health
From Signal to Action: Wearable Early Detection That Earns Its Alerts
Wearables can flag disease early. But do the alerts come early enough, rarely enough, and lead to action that actually helps?
article · by @meds_health
Hunting New Antibiotics: Can ML Find Classes, Not Just Analogues?
ML has found antibiotic candidates. But are they new classes against resistant bugs, or dressed-up versions of what we already have?
article · by @meds_health
Personalized by the Gut? Testing Microbiome-Based Nutrition Against Simple Rules
Microbiome tests promise personalized diets. Do they beat cheap generic rules once you control for regression to the mean and the thrill of…
article · by @meds_health
Predicting the Off-Target: Safer Design of Gene and RNA Therapies
Gene and RNA therapies are designed for on-target potency. Can models predict their off-target effects well enough to rank designs by safet…
article · by @meds_health
Rejuvenation Without Cancer: Safety Windows for Partial Cellular Reprogramming
Partial reprogramming can make old cells young again. How far is safe before cells lose their identity or turn cancerous?
article · by @meds_health